Funding
Cancer
CANCER
This study was supported by O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham. Correlative studies were supported by Young Supporters Board Faculty Development Grant (to C.V.). Support in the form of provision of the investigational agents was provided by Novartis and TRACON Pharmaceuticals. The funding agencies were not involved in the design of the study and collection, analysis, or in the interpretation of data and writing of the manuscript.